Recursion Pharmaceuticals, Inc. (RXRX)
3.98
+0.42
(+11.80%)
USD |
NASDAQ |
Feb 06, 16:00
3.97
-0.01
(-0.25%)
After-Hours: 20:00
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.363 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| XOMA Royalty Corp. | 0.6991 |
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Hims & Hers Health, Inc. | 0.0634 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -162.25M |
| Revenue (Quarterly) | 5.175M |
| Total Expenses (Quarterly) | 167.43M |
| Enterprise Value | 1.491B |
| Gross Profit Margin (Quarterly) | -442.7% |
| Profit Margin (Quarterly) | -3.14K% |
| Earnings Yield | -45.48% |
| Normalized Earnings Yield | -45.48 |